Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients

European Journal of Radiology

Volumn 60, Issue 2, 2006, Pages 270-274

  Nagashima, Takeshi ^a   Sakakibara, Masahiro ^a   Nakamura, Rikiya ^a   Arai, Manabu ^a   Kadowaki, Masami ^a   Kazama, Toshiki ^a   Nakatani, Yukio ^a   Koda, Keiji ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast neoplasms; Carcinoma; Chemotherapy; Dynamic imaging; MRI

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; SENSITIVITY ANALYSIS; STATISTICAL METHODS; SURGERY; TUMORS;

BREAST NEOPLASMS; DYNAMIC IMAGING; PATHOLOGICAL TUMOR DIMENSION;

MAGNETIC RESONANCE IMAGING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33750364880     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2006.07.014     Document Type: Article

References (18)

1. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
2. Ikeda T., Jinno H., Matsu A., Masamura S., and Kitajima M. The role of neoadjuvant chemotherapy for breast cancer treatment. Breast Cancer 9 (2002) 8-14
3. Leach M.O. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res 3 (2001) 22-27
4. Martincich L., Montemurro F., De Rosa G., et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83 (2004) 67-76
5. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
6. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
7. Jacquemier J.D., Penault-Llorca F.M., Bertucci F., et al. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol 184 (1998) 130-135
8. Gasparini G., Barbareschi M., Boracchi P., et al. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sci Am 1 (1995) 131
9. Protopapa E., Delides G.S., and Revesz L. Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Eur J Cancer 29 (1993) 1391-1393
10. Buadu L.D., Murakami J., Murayama S., et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200 (1996) 639-649
11. Buckley D.L., Drew P.J., Mussurakis S., Monson J.R., and Horsman A. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 7 (1997) 461-464
12. Reddick W.E., Bhargava R., Taylor J.S., Meyer W.H., and Fletcher B.D. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 5 (1995) 689-694
13. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 94 (2006) 427-435
14. Pickles M.D., Lowry M., Manton D.J., Gibbs P., and Turnbull L.W. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 91 (2005) 1-10
15. Partridge S.C., Gibbs J.E., Lu Y., Esserman L.J., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. Am J Roentgenol 184 (2005) 1774-1781
16. Kuhl C.K., Bieling H., Gieseke J., et al. Breast neoplasms: T2 susceptibility-contrast, first-pass perfusion MR imaging. Radiology 202 (1997) 87-95
17. Montemurro F., Martincich L., De Rosa G., et al. Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer. Eur Radiol 15 (2005) 1224-1233
18. Julius T., Kemp S.E., Kneeshaw P.J., Chaturvedi A., Drew P.J., and Turnbull L.W. MRI and conservative treatment of locally advanced breast cancer. Eur J Surg Oncol 31 (2005) 1129-1134